{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:49:56Z","timestamp":1793321396536,"version":"4.5.0"},"reference-count":102,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2023,9,2]]},"DOI":"10.1080\/17512433.2023.2243213","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T04:01:11Z","timestamp":1690948871000},"page":"775-790","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Clinical pharmacology of emicizumab for the treatment of hemophilia A"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8166-6522","authenticated-orcid":false,"given":"Koichiro","family":"Yoneyama","sequence":"first","affiliation":[{"name":"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-5584","authenticated-orcid":false,"given":"Christophe","family":"Schmitt","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Portron","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-9649","authenticated-orcid":false,"given":"Anna","family":"Kiialainen","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-1370","authenticated-orcid":false,"given":"Naoki","family":"Kotani","sequence":"additional","affiliation":[{"name":"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Jaminion","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-8438","authenticated-orcid":false,"given":"Sylvie","family":"Retout","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-988X","authenticated-orcid":false,"given":"Joanne I","family":"Adamkewicz","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.06.002"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_6_5_1","unstructured":"World Federation of Hemophilia. Report on the annual global survey 2021. [cited 2023 Mar] Available at: https:\/\/www1.wfh.org\/publications\/files\/pdf-2324.pdf"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615621"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12695"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01123-X"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02838.x"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620712464509"},{"key":"e_1_3_6_13_1","unstructured":"European Medicines Agency. HEMLIBRA\u00ae solution for injection product information [Initial EU approval: 2018]. [cited 2023 Mar]. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/hemlibra-epar-product-information_en.pdf"},{"key":"e_1_3_6_14_1","unstructured":"Genentech Inc. HEMLIBRA\u00ae (emicizumab-kxwh) injection for subcutaneous use prescribing information [Initial U.S. approval: 2017]. [cited 2023 Mar] Available at: https:\/\/www.gene.com\/download\/pdf\/hemlibra_prescribing.pdf"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2942"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057479"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)00025-0"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH17-01-0030"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12474"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511769"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-650226"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006684"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30054-7"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.617"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018943613122"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.805"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00904-z"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32722-7"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002699"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006119"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209226"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-012-0027-4"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzq009"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703068"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001869"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803550"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12670"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13848"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12837"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00377-5"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0616-3"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1968"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-144549"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1717114"},{"issue":"1","key":"e_1_3_6_45_1","first-page":"45","article-title":"Pharmacokinetics and biomarkers in persons with haemophilia A (PwHA) receiving emicizumab every 2 or 4 weeks","volume":"25","author":"Kiialainen A","year":"2019","unstructured":"Kiialainen A, Schmitt C, Adamkewicz JI, et al. Pharmacokinetics and biomarkers in persons with haemophilia A (PwHA) receiving emicizumab every 2 or 4 weeks. Haemophilia. 2019;25(Suppl 1):45\u201346.","journal-title":"Haemophilia"},{"issue":"1","key":"e_1_3_6_46_1","first-page":"46","article-title":"Pharmacokinetics and biomarkers in persons with haemophilia A (PwHA) without FVIII inhibitors receiving emicizumab once weekly in the phase 3 HAVEN 3 study","volume":"25","author":"Kiialainen A","year":"2019","unstructured":"Kiialainen A, Schmitt C, Oldenburg J, et al. Pharmacokinetics and biomarkers in persons with haemophilia A (PwHA) without FVIII inhibitors receiving emicizumab once weekly in the phase 3 HAVEN 3 study. Haemophilia. 2019;25(Suppl 1):46\u201347.","journal-title":"Haemophilia"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688687"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13114"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14398"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-801662"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000849"},{"key":"e_1_3_6_52_1","unstructured":"Emicizumab Calibrator. [cited Mar 2023]. Available at: https:\/\/r2diagnostics.com\/wp-content\/uploads\/2022\/08\/Emi-Calibrator_IFU.pdf"},{"key":"e_1_3_6_53_1","unstructured":"Emicizumab Controls Level 1 and Level 2. [cited 2023 Mar]. Available at: https:\/\/r2diagnostics.com\/wp-content\/uploads\/2022\/08\/Emi-Controls-1-and-2_IFU.pdf"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14177"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271330"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12725"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14330"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02698-8"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14022"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1710315"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14135"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221143382"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14205"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14491"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36891-x"},{"issue":"2","key":"e_1_3_6_66_1","first-page":"26","article-title":"In vitro thrombin generation testing and in vivo venous stasis model for assessing the pro-coagulant effects of FVIII, emicizumab, rFVIIa, and aPCC","volume":"23","author":"Adamkewicz JI","year":"2017","unstructured":"Adamkewicz JI, Muto A, Soeda T, et al. In vitro thrombin generation testing and in vivo venous stasis model for assessing the pro-coagulant effects of FVIII, emicizumab, rFVIIa, and aPCC. Haemophilia. 2017;23(Suppl 2):26\u201327.","journal-title":"Haemophilia"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14203"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02959-x"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14887"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004334"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146147"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13495"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13817"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.2450\/2019.0186-19"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009217"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01006-0"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14679"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01042-w"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02383.x"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-07-0492"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14757"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14110"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9599-2"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15226"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14334"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12475"},{"key":"e_1_3_6_87_1","article-title":"A model-based extrapolation enabled labelling of emicizumab in haemophilia A paediatric patients <1 year old despite lack of clinical data","volume":"28","author":"Retout S","year":"2019","unstructured":"Retout S, Grimm HP, Petry C, et al. A model-based extrapolation enabled labelling of emicizumab in haemophilia A paediatric patients <1 year old despite lack of clinical data. PAGE. 2019 [cited Mar 2023];28. Abstract 9089Available at: https:\/\/www.page-meeting.org\/?abstract=9089","journal-title":"PAGE"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-esdppp.127"},{"key":"e_1_3_6_89_1","unstructured":"A study to evaluate the efficacy safety pharmacokinetics and pharmacodynamics of subcutaneous emicizumab in participants from birth to 12 months of age with hemophilia A without inhibitors (HAVEN 7). [cited 2023Mar]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04431726"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2022.10.004"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12760"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-138958"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616569"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15270"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001542"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006403"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14595"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18420"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18495"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12576"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810228"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708483"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908490"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2113708"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2023.2243213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T11:56:06Z","timestamp":1702554966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2023.2243213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,2]]}},"alternative-id":["10.1080\/17512433.2023.2243213"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2023.2243213","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}